SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ:AFFX) (the “Company”) today announced that the U.S. District Court for the Western District of Wisconsin (the “Court”) has granted the company’s motion for summary judgment that Affymetrix does not infringe the patents held by Illumina, Inc. (NASDAQ: ILMN), and has directed that the patent infringement lawsuits brought against […]

SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE: A) today announced that its SureSelect Target Enrichment System now supports the 454 Life Sciences next-generation sequencing platform, boosting efficiency and cost-effectiveness of research by enabling users to sequence just genomic regions of interest rather than entire genomes. “The SureSelect Target Enrichment Kits are now optimized and […]

Genovis, a producer of new technologies used for Imaging and Antibody Engineering, today announced that it has entered into an agreement with ADVANSYS Technologies for Life Ltd. to exclusive distribute its products on the Israeli market. Genovis provides novel technical solutions for Imaging and Antibody Engineering. The objectives are to maintain a strong, collaborative and […]

MADISON, WISCONSIN – Promega Corporation reinforces its commitment to socially responsible business practices on a worldwide basis by signing the United Nations Global Compact. The UN Global Compact is a policy initiative for businesses that are committed to supporting the Compact’s ten universally accepted principles in the areas of human rights, labour, environment and anti-corruption. […]

Fremont, Calif. – WaferGen Biosystems, Inc. (OTCBB:WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced that its Malaysian subsidiary, WaferGen Biosystems (M) Sdn. Bhd., has signed a purchase agreement with an investor for a $5 million private placement of the Malaysian subsidiary’s Series C-1 redeemable convertible preference shares. WaferGen also announced that it […]

Burlingame, CA – Epitomics and NCI to Develop Novel Antibodies Using Epitomics Technology Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) […]

Biotechnology Progress Paper Details Hidden Information in Cell Size Distributions ORANGE COUNTY, CALIF. – In a paper published in the November/December 2010 issue of Biotechnology Progress (Vol. 26, No. 6) the authors use the large amounts of data generated by Beckman Coulter’s Multisizer COULTER COUNTER to infer significant and detailed information about cells infected with […]

Biodegradable transfection reagents now available through e-commerce site PHILADELPHIA – Techulon Inc., an early stage life sciences company has joined KFP—the KeraFAST Partner Program, adding its innovative new transfection reagent, Glycofect™, to KeraFAST’s portfolio of research products for the cell biologist. The agreement was announced during the 50th Annual Meeting of the American Society for […]

Horizon Discovery (Horizon), a leading provider of research tools to support the development of personalized medicines,has announced that it will commit resources to provide training and open access to its rAAV GENESIS human gene-editing platform for another 50 academic and not-for-profit research groups over the next five years, extending the GENESIS Gene Editing Consortium. This […]

PENZBERG, Germany – The new xCELLigence System RTCA HT Instrument from Roche Diagnostics (SIX:RO)(SIX:ROG)(OTCQX:RHHBY) rounds out the company’s portfolio in real-time cell analysis with a high-throughput product. The new instrument merges the power and flexibility of xCELLigence System technology with high-throughput analyses and workflows for automated screening applications. The system allows researchers to run 1 […]